BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: She Q, Huang C, Zhang Y, Dong Z. Involvement of c-jun NH2-terminal kinases in resveratrol-induced activation of p53 and apoptosis. Mol Carcinog 2002;33:244-50. [DOI: 10.1002/mc.10041] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Wen S, Zhang J, Yang B, Elias PM, Man MQ. Role of Resveratrol in Regulating Cutaneous Functions. Evid Based Complement Alternat Med 2020;2020:2416837. [PMID: 32382280 DOI: 10.1155/2020/2416837] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
2 Roy M, Datta A. Molecular Mechanisms of Phytochemical Actions in Cancer. Cancer Genetics and Therapeutics 2019. [DOI: 10.1007/978-981-13-9471-3_5] [Reference Citation Analysis]
3 Zhang R, Che X, Zhang J, Li Y, Li J, Deng X, Zhu J, Jin H, Zhao Q, Huang C. Cheliensisin A (Chel A) induces apoptosis in human bladder cancer cells by promoting PHLPP2 protein degradation. Oncotarget 2016;7:66689-99. [PMID: 27556506 DOI: 10.18632/oncotarget.11440] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
4 Ko JH, Sethi G, Um JY, Shanmugam MK, Arfuso F, Kumar AP, Bishayee A, Ahn KS. The Role of Resveratrol in Cancer Therapy. Int J Mol Sci 2017;18:E2589. [PMID: 29194365 DOI: 10.3390/ijms18122589] [Cited by in Crossref: 332] [Cited by in F6Publishing: 355] [Article Influence: 55.3] [Reference Citation Analysis]
5 Wu Y, Honegger A, Batyuk A, Mittl PRE, Plückthun A. Structural Basis for the Selective Inhibition of c-Jun N-Terminal Kinase 1 Determined by Rigid DARPin-DARPin Fusions. J Mol Biol 2018;430:2128-38. [PMID: 29126898 DOI: 10.1016/j.jmb.2017.10.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
6 Ortega I, Duleba AJ. Ovarian actions of resveratrol. Ann N Y Acad Sci 2015;1348:86-96. [PMID: 26315293 DOI: 10.1111/nyas.12875] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
7 Antus C, Radnai B, Dombovari P, Fonai F, Avar P, Matyus P, Racz B, Sumegi B, Veres B. Anti-inflammatory effects of a triple-bond resveratrol analog: Structure and function relationship. European Journal of Pharmacology 2015;748:61-7. [DOI: 10.1016/j.ejphar.2014.12.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
8 Lee J, Jo DG, Park D, Chung HY, Mattson MP. Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system. Pharmacol Rev 2014;66:815-68. [PMID: 24958636 DOI: 10.1124/pr.113.007757] [Cited by in Crossref: 106] [Cited by in F6Publishing: 108] [Article Influence: 13.3] [Reference Citation Analysis]
9 Cordero-Herrera I, Martín MA, Bravo L, Goya L, Ramos S. Epicatechin gallate induces cell death via p53 activation and stimulation of p38 and JNK in human colon cancer SW480 cells. Nutr Cancer. 2013;65:718-728. [PMID: 23859040 DOI: 10.1080/01635581.2013.795981] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
10 Connor CA, Adriaens M, Pierini R, Johnson IT, Belshaw NJ. Procyanidin induces apoptosis of esophageal adenocarcinoma cells via JNK activation of c-Jun. Nutr Cancer 2014;66:335-41. [PMID: 24471892 DOI: 10.1080/01635581.2014.868914] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
11 Borriello A, Bencivenga D, Caldarelli I, Tramontano A, Borgia A, Zappia V, Della Ragione F. Resveratrol: from basic studies to bedside. Cancer Treat Res 2014;159:167-84. [PMID: 24114480 DOI: 10.1007/978-3-642-38007-5_10] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 6.0] [Reference Citation Analysis]
12 Catalgol B, Batirel S, Taga Y, Ozer NK. Resveratrol: French paradox revisited. Front Pharmacol. 2012;3:141. [PMID: 22822401 DOI: 10.3389/fphar.2012.00141] [Cited by in Crossref: 270] [Cited by in F6Publishing: 289] [Article Influence: 24.5] [Reference Citation Analysis]
13 Singh N, Zaidi D, Shyam H, Sharma R, Balapure AK. Polyphenols sensitization potentiates susceptibility of MCF-7 and MDA MB-231 cells to Centchroman. PLoS One 2012;7:e37736. [PMID: 22768036 DOI: 10.1371/journal.pone.0037736] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
14 Herbert KJ, Snow ET. Modulation of arsenic-induced epidermal growth factor receptor pathway signalling by resveratrol. Chem Biol Interact 2012;198:38-48. [PMID: 22634503 DOI: 10.1016/j.cbi.2012.05.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
15 Latruffe N, Delmas D, Lizard G, Tringali C, Spatafora C, Vervandier-fasseur D, Meunier P. Resveratrol against Major Pathologies. Bioactive Compounds from Natural Sources, Second Edition 2011. [DOI: 10.1201/b11196-11] [Reference Citation Analysis]
16 Li G, He S, Chang L, Lu H, Zhang H, Zhang H, Chiu J. GADD45α and annexin A1 are involved in the apoptosis of HL-60 induced by resveratrol. Phytomedicine 2011;18:704-9. [DOI: 10.1016/j.phymed.2010.11.015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
17 Kumar AP, Graham H, Robson C, Garapati K, Ghosh R. An Overview of Anticancer Herbal Medicines. Evidence-based Anticancer Materia Medica 2011. [DOI: 10.1007/978-94-007-0526-5_1] [Reference Citation Analysis]
18 Oi N, Jeong CH, Nadas J, Cho YY, Pugliese A, Bode AM, Dong Z. Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A₄hydrolase. Cancer Res 2010;70:9755-64. [PMID: 20952510 DOI: 10.1158/0008-5472.CAN-10-2858] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 6.1] [Reference Citation Analysis]
19 Fukui M, Yamabe N, Kang KS, Zhu BT. Growth-stimulatory effect of resveratrol in human cancer cells. Mol Carcinog 2010;49:750-9. [PMID: 20572158 DOI: 10.1002/mc.20650] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
20 Fukui M, Choi HJ, Zhu BT. Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radic Biol Med 2010;49:800-13. [PMID: 20542495 DOI: 10.1016/j.freeradbiomed.2010.06.002] [Cited by in Crossref: 150] [Cited by in F6Publishing: 140] [Article Influence: 11.5] [Reference Citation Analysis]
21 Mukherjee S, Dudley JI, Das DK. Dose-dependency of resveratrol in providing health benefits. Dose Response 2010;8:478-500. [PMID: 21191486 DOI: 10.2203/dose-response.09-015.Mukherjee] [Cited by in Crossref: 159] [Cited by in F6Publishing: 166] [Article Influence: 12.2] [Reference Citation Analysis]
22 Fukui M, Yamabe N, Zhu BT. Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo. Eur J Cancer 2010;46:1882-91. [PMID: 20223651 DOI: 10.1016/j.ejca.2010.02.004] [Cited by in Crossref: 87] [Cited by in F6Publishing: 94] [Article Influence: 6.7] [Reference Citation Analysis]
23 Puissant A, Robert G, Fenouille N, Luciano F, Cassuto JP, Raynaud S, Auberger P. Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. Cancer Res 2010;70:1042-52. [PMID: 20103647 DOI: 10.1158/0008-5472.CAN-09-3537] [Cited by in Crossref: 278] [Cited by in F6Publishing: 289] [Article Influence: 21.4] [Reference Citation Analysis]
24 Pervaiz S, Holme AL. Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal 2009;11:2851-97. [PMID: 19432534 DOI: 10.1089/ars.2008.2412] [Cited by in Crossref: 297] [Cited by in F6Publishing: 310] [Article Influence: 21.2] [Reference Citation Analysis]
25 Kondratyuk TP, Pezzuto JM. Natural Product Polyphenols of Relevance to Human Health. Pharmaceutical Biology 2009;42:46-63. [DOI: 10.3109/13880200490893519] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 5.6] [Reference Citation Analysis]
26 Cao R, Cao Y, Brakenhielm E. Resveratrol as an Angiogenesis Inhibitor. In: Aggarwal B, Shishodia S, editors. Resveratrol in Health and Disease. CRC Press; 2005. pp. 149-65. [DOI: 10.1201/9781420026474.ch9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Neergheen VS, Bahorun T, Taylor EW, Jen LS, Aruoma OI. Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention. Toxicology. 2010;278:229-241. [PMID: 19850100 DOI: 10.1016/j.tox.2009.10.010] [Cited by in Crossref: 112] [Cited by in F6Publishing: 94] [Article Influence: 8.0] [Reference Citation Analysis]
28 Hwang MK, Song NR, Kang NJ, Lee KW, Lee HJ. Activation of phosphatidylinositol 3-kinase is required for tumor necrosis factor-alpha-induced upregulation of matrix metalloproteinase-9: its direct inhibition by quercetin. Int J Biochem Cell Biol 2009;41:1592-600. [PMID: 19401153 DOI: 10.1016/j.biocel.2009.01.014] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 4.5] [Reference Citation Analysis]
29 Lee KW, Kang NJ, Rogozin EA, Oh SM, Heo YS, Pugliese A, Bode AM, Lee HJ, Dong Z. The resveratrol analogue 3,5,3',4',5'-pentahydroxy-trans-stilbene inhibits cell transformation via MEK. Int J Cancer 2008;123:2487-96. [PMID: 18767048 DOI: 10.1002/ijc.23830] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
30 Pezzuto JM. Resveratrol as an Inhibitor of Carcinogenesis. Pharmaceutical Biology 2008;46:443-573. [DOI: 10.1080/13880200802116610] [Cited by in Crossref: 64] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
31 Zykova TA, Zhu F, Zhai X, Ma WY, Ermakova SP, Lee KW, Bode AM, Dong Z. Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol Carcinog 2008;47:797-805. [PMID: 18381589 DOI: 10.1002/mc.20437] [Cited by in Crossref: 140] [Cited by in F6Publishing: 142] [Article Influence: 9.3] [Reference Citation Analysis]
32 Kumar Kundu J, Na H, Surh Y. Intracellular Signaling Molecules as Targets of Selected Dietary Chemopreventive Agents. Oxidative Stress and Disease 2008. [DOI: 10.1201/9780849381492.ch1] [Reference Citation Analysis]
33 Biswas S, Rahman I. Regulation of Inflammation, Redox, and Glucocorticoid Signaling by Dietary Polyphenols. Oxidative Stress and Disease 2008. [DOI: 10.1201/9780849381492.ch6] [Reference Citation Analysis]
34 Kundu JK, Surh YJ. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 2008;269:243-261. [PMID: 18550275 DOI: 10.1016/j.canlet.2008.03.057] [Cited by in Crossref: 346] [Cited by in F6Publishing: 360] [Article Influence: 23.1] [Reference Citation Analysis]
35 Saracino MR, Lampe JW. Phytochemical regulation of UDP-glucuronosyltransferases: implications for cancer prevention. Nutr Cancer 2007;59:121-41. [PMID: 18001207 DOI: 10.1080/01635580701458178] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
36 Chen Y, Kuo C, Tsai Y, Yu C, Wang G, Liao H. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells. Anti-Cancer Drugs 2008;19:55-64. [DOI: 10.1097/cad.0b013e3282f18826] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 3.6] [Reference Citation Analysis]
37 Howells LM, Moiseeva EP, Neal CP, Foreman BE, Andreadi CK, Sun YY, Hudson EA, Manson MM. Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals. Acta Pharmacol Sin 2007;28:1274-304. [PMID: 17723163 DOI: 10.1111/j.1745-7254.2007.00690.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 5.3] [Reference Citation Analysis]
38 Saiko P, Szakmary A, Jaeger W, Szekeres T. Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat Res 2008;658:68-94. [PMID: 17890139 DOI: 10.1016/j.mrrev.2007.08.004] [Cited by in Crossref: 334] [Cited by in F6Publishing: 345] [Article Influence: 20.9] [Reference Citation Analysis]
39 Woo KJ, Lee TJ, Lee SH, Lee J, Seo J, Jeong Y, Park J, Kwon TK. Elevated gadd153/chop expression during resveratrol-induced apoptosis in human colon cancer cells. Biochemical Pharmacology 2007;73:68-76. [DOI: 10.1016/j.bcp.2006.09.015] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 3.4] [Reference Citation Analysis]
40 Faber AC, Dufort FJ, Blair D, Wagner D, Roberts MF, Chiles TC. Inhibition of phosphatidylinositol 3-kinase-mediated glucose metabolism coincides with resveratrol-induced cell cycle arrest in human diffuse large B-cell lymphomas. Biochemical Pharmacology 2006;72:1246-56. [DOI: 10.1016/j.bcp.2006.08.009] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 3.2] [Reference Citation Analysis]
41 Rahman I, Biswas SK, Kirkham PA. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol. 2006;72:1439-1452. [PMID: 16920072 DOI: 10.1016/j.bcp.2006.07.004] [Cited by in Crossref: 696] [Cited by in F6Publishing: 715] [Article Influence: 40.9] [Reference Citation Analysis]
42 Alkhalaf M, Jaffal S. Potent antiproliferative effects of resveratrol on human osteosarcoma SJSA1 cells: novel cellular mechanisms involving the ERKs/p53 cascade. Free Radical Biology and Medicine 2006;41:318-25. [DOI: 10.1016/j.freeradbiomed.2006.04.019] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 2.4] [Reference Citation Analysis]
43 Lin H, Lansing L, Merillon J, Davis FB, Tang H, Shih A, Vitrac X, Krisa S, Keating T, Cao HJ, Bergh J, Quackenbush S, Davis PJ, Lin H, Lansing L, Merillon J, Davis FB, Tang H, Shih A, Vitrac X, Krisa S, Keating T, Cao HJ, Bergh J, Quackenbush S, Davis PJ. Integrin αVβ3 contains a receptor site for resveratrol. FASEB j 2006;20:1742-4. [DOI: 10.1096/fj.06-5743fje] [Cited by in Crossref: 117] [Cited by in F6Publishing: 123] [Article Influence: 6.9] [Reference Citation Analysis]
44 Gulati AP, Yang YM, Harter D, Mukhopadhyay A, Aggarwal BB, Benzil DL, Whysner J, Albino AP, Murali R, Jhanwar-Uniyal M. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1. Mol Carcinog 2006;45:26-37. [PMID: 16267831 DOI: 10.1002/mc.20149] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
45 Das S, Tosaki A, Bagchi D, Maulik N, Das DK. Potentiation of a Survival Signal in the Ischemic Heart by Resveratrol through p38 Mitogen-Activated Protein Kinase/Mitogen- and Stress-Activated Protein Kinase 1/cAMP Response Element-Binding Protein Signaling. J Pharmacol Exp Ther 2006;317:980-8. [DOI: 10.1124/jpet.105.095133] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 3.8] [Reference Citation Analysis]
46 In K, Park J, Park H. Resveratrol at high doses acts as an apoptotic inducer in endothelial cells. Cancer Res Treat 2006;38:48-53. [PMID: 19771259 DOI: 10.4143/crt.2006.38.1.48] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
47 Fulda S, Debatin K. Resveratrol modulation of signal transduction in apoptosis and cell survival: A mini-review. Cancer Detection and Prevention 2006;30:217-23. [DOI: 10.1016/j.cdp.2006.03.007] [Cited by in Crossref: 108] [Cited by in F6Publishing: 113] [Article Influence: 6.4] [Reference Citation Analysis]
48 Crowell JA. The chemopreventive agent development research program in the Division of Cancer Prevention of the US National Cancer Institute: an overview. Eur J Cancer. 2005;41:1889-1910. [PMID: 16005206 DOI: 10.1016/j.ejca.2005.04.016] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 2.6] [Reference Citation Analysis]
49 Masella R, Di Benedetto R, Varì R, Filesi C, Giovannini C. Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. J Nutr Biochem 2005;16:577-86. [PMID: 16111877 DOI: 10.1016/j.jnutbio.2005.05.013] [Cited by in Crossref: 673] [Cited by in F6Publishing: 692] [Article Influence: 37.4] [Reference Citation Analysis]
50 Pervaiz S, Lisa Holme A. Mechanism of Apoptosis by Resveratrol. Oxidative Stress and Disease 2005. [DOI: 10.1201/9781420026474.ch5] [Reference Citation Analysis]
51 Narayanan N, Narayanan B. Modulation of Gene Expression by Resveratrol. Oxidative Stress and Disease 2005. [DOI: 10.1201/9781420026474.ch11] [Reference Citation Analysis]
52 Pezzuto J. Resveratrol as an Inhibitor of Carcinogenesis. Oxidative Stress and Disease 2005. [DOI: 10.1201/9781420026474.ch13] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Young LF, Hantz HL, Martin KR. Resveratrol modulates gene expression associated with apoptosis, proliferation and cell cycle in cells with mutated human c-Ha-Ras, but does not alter c-Ha-Ras mRNA or protein expression. The Journal of Nutritional Biochemistry 2005;16:663-74. [DOI: 10.1016/j.jnutbio.2005.03.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
54 Debatin K, Fulda S. Resveratrol as Inhibitor of Cell Survival Signal Transduction. Oxidative Stress and Disease 2005. [DOI: 10.1201/9781420026474.ch6] [Reference Citation Analysis]
55 Stewart J, Chu F, O'brian C. Cancer Chemoprotective Activity of Stilbenes. Nutrition and Cancer Prevention 2005. [DOI: 10.1201/9781420026399.ch18] [Reference Citation Analysis]
56 Kutuk O, Basaga H. Phytoestrogens in Cell Signaling. Phytoestrogens In Functional Foods 2005. [DOI: 10.1201/9781420027594.ch5] [Reference Citation Analysis]
57 Ulrich S, Wolter F, Stein JM. Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis. Mol Nutr Food Res 2005;49:452-61. [DOI: 10.1002/mnfr.200400081] [Cited by in Crossref: 106] [Cited by in F6Publishing: 108] [Article Influence: 5.9] [Reference Citation Analysis]
58 Zhou HB, Chen JJ, Wang WX, Cai JT, Du Q. Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J Gastroenterol 2005; 11(2): 280-284 [PMID: 15633232 DOI: 10.3748/wjg.v11.i2.280] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 74] [Article Influence: 3.8] [Reference Citation Analysis]
59 Wang Z, Hsieh TC, Zhang Z, Ma Y, Wu JM. Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography. Biochem Biophys Res Commun 2004;323:743-9. [PMID: 15381063 DOI: 10.1016/j.bbrc.2004.08.174] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 3.1] [Reference Citation Analysis]
60 Kundu JK, Surh YJ. Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat Res 2004;555:65-80. [PMID: 15476852 DOI: 10.1016/j.mrfmmm.2004.05.019] [Cited by in Crossref: 165] [Cited by in F6Publishing: 132] [Article Influence: 8.7] [Reference Citation Analysis]
61 Bode A, Dong Z. Beneficial Effects of Resveratrol. Oxidative Stress and Disease 2004. [DOI: 10.1201/9780203021408.ch13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
62 Bode AM, Dong Z. Cancer prevention by food factors through targeting signal transduction pathways. Nutrition 2004;20:89-94. [DOI: 10.1016/j.nut.2003.09.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
63 Yao YL, Xu B, Song YG, Zhang WD. c-met and c-Jun expression during acute gastric mucosal lesions in rats. Shijie Huaren Xiaohua Zazhi 2003; 11(11): 1711-1714 [DOI: 10.11569/wcjd.v11.i11.1711] [Reference Citation Analysis]
64 Loo G. Redox-sensitive mechanisms of phytochemical-mediated inhibition of cancer cell proliferation (review). J Nutr Biochem. 2003;14:64-73. [PMID: 12667597 DOI: 10.1016/s0955-2863(02)00251-6] [Cited by in Crossref: 156] [Cited by in F6Publishing: 163] [Article Influence: 7.8] [Reference Citation Analysis]
65 Maccaglia A, Mallozzi C, Minetti M. Differential effects of quercetin and resveratrol on Band 3 tyrosine phosphorylation signalling of red blood cells. Biochemical and Biophysical Research Communications 2003;305:541-7. [DOI: 10.1016/s0006-291x(03)00762-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
66 Dong Z. Molecular mechanism of the chemopreventive effect of resveratrol. Mutat Res. 2003;523-524:145-150. [PMID: 12628512 DOI: 10.1016/s0027-5107(02)00330-5] [Cited by in Crossref: 153] [Cited by in F6Publishing: 166] [Article Influence: 7.7] [Reference Citation Analysis]
67 She Q, Ma W, Wang M, Kaji A, Ho C, Dong Z. Inhibition of cell transformation by resveratrol and its derivatives: differential effects and mechanisms involved. Oncogene 2003;22:2143-50. [DOI: 10.1038/sj.onc.1206370] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 2.3] [Reference Citation Analysis]
68 Zhou HB, Yan Y, Sun YN, Zhu JR. Resveratrol induces apoptosis in human esophageal carcinoma cells. World J Gastroenterol 2003; 9(3): 408-411 [PMID: 12632486 DOI: 10.3748/wjg.v9.i3.408] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 55] [Article Influence: 2.6] [Reference Citation Analysis]
69 Brownson DM, Azios NG, Fuqua BK, Dharmawardhane SF, Mabry TJ. Flavonoid Effects Relevant to Cancer. The Journal of Nutrition 2002;132:3482S-9S. [DOI: 10.1093/jn/132.11.3482s] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 3.4] [Reference Citation Analysis]